Gregory Beatty

Associate Professor

University of Pennsylvania

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Gregory Beatty is an Associate Professor at the University of Pennsylvania, USA. His research primarily focuses on the mechanisms of therapeutic resistance in pancreatic cancer and the role of immune checkpoints in cancer immunotherapy. Recent publications include explorations of CD40 agonists, tumor proliferation indexes, and the dynamics of dendritic cells in oncogenesis. Dr. Beatty's work integrates insights into both innate and adaptive immunity to enhance cancer treatment strategies.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

David M. Feldser

University of Pennsylvania

UNITED STATES

View details

Max Wattenberg

Assistant Professor

Washington University in St. Louis

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gregory Beatty

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Non-redundant immune checkpoints direct therapeutic resistance to chemoimmunotherapy in pancreatic ductal adenocarcinoma

Facts and Hopes of CD40 Agonists in Cancer Immunotherapy

Exogenous or in situ vaccination to trigger clinical responses in pancreatic cancer

Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration

The biological underpinnings of therapeutic resistance in pancreatic cancer

Systemic inflammation is a determinant of outcomes of CD40 agonist–based therapy in pancreatic cancer patients

Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis

The interplay between innate and adaptive immunity in cancer shapes the productivity of cancer immunosurveillance

Inflammatory networks cultivate cancer cell metastasis to the liver

Paracrine and cell autonomous signalling in pancreatic cancer progression and metastasis

Collaborators (2)

David M. Feldser

Max Wattenberg

Make your next move.